This American Express Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Raymond James Initiates Coverage On Kymera Therapeutics with Outperform Rating, Announces Price Target of $140
Kymera Therapeutics, Inc. (KYMR) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript